The prognosis for patients with IMTs is generally favorable, especially when the tumor is completely removed surgically. Recurrence rates vary but are higher in cases where complete excision is not possible. The presence of ALK rearrangements may influence responsiveness to targeted therapies, providing additional treatment options for recurrent or unresectable tumors. Regular follow-up and monitoring are essential to detect any signs of recurrence early.
